Colzyx is led by a highly qualified, interdisciplinary team with broad experience in life science and research successes published in peer-reviewed journals. Along with the proven track record in bioscience research, our team is highly skilled in business development and project management.
Dr Eskil Söderlind, CEO
Eskil has more than 25 years of business experience in life sciences and has been instrumental in the incorporation of more than 10 different companies. Eskil has an established network of contacts in the MedTech industry crucial for the project. Eskil has a PhD in molecular biology from Uppsala and holds an MBA-diploma. Eskil is a founder of Colzyx and the CEO of Colzyx.
Dr Karin Bryder
Karin has a vast experience from start up companies in life sciences. Her work spans from reasearch and method development of vaccines and virus diagnostics through protein pharmaceuticals, small molecule developmens and patent portfolio management. Karin has in the last few years worked extensively with medical device devlopment as project manager and CEO. Karin is a co-founder of Colzyx and act as the chairman of the board.
Dr Matthias Mörgelin
Matthias is the key inventor to Colzyx’ patent applications and has discovered the unique properties of human collagen VI. Matthias holds a PhD in Natural Sciences from Basel University and has more than 30 years of academic experience in life science. Matthias is a founder of Colzyx and the CTO of Colzyx.
Jens has two decades of experience from private equity and venture capital investments. He is an engineer by trade and has prior to his career within the finance industry acted in leading industrial positions and as CEO for a publicly traded company. Jens currently acts as partner at private equity firm Dedicap AB. Jens is a board member in Colzyx